Meridian Receives FDA Approval for the Lapex-2000 a Low-Level Laser Therapy Device

Abstract

(CCNMatthews - March 14, 2005) - Meridian Co., Ltd. ("Meridian" or the "Company") (OTCBB:MRDAF), is very pleased to receive FDA approval for its low-level laser therapy device, the Lapex-2000.

The Lapex-2000 uses low-level laser therapy ("LLLT"), which delivers a laser light to various areas of the body without damaging the skin tissue. The light source is placed in contact with the skin allowing the photon energy to penetrate tissue. The body then coverts the photon energy into biochemical energy by interacting with cellular structures resulting in the restoration of normal cell function and enhancement of the body's natural healing process. The Lapex-2000 is digitally controlled with an LCD screen and is easy to operate.